What You Need to Know About CBD Medicare Coverage: Last Week in Weed Feb. 10-16, 2026

Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.

Here’s what you may have missed over the last week:

Chicago Mayor Blocks Hemp THC Sales Ban, Preserving Retail Market Access

Chicago’s political arena delivered one of the biggest cannabis headlines this week when Mayor Brandon Johnson vetoed the city council’s attempt to ban intoxicating hemp-derived products statewide. The proposed ordinance would have restricted intoxicating THC items, like gummies, vapes, and oils, to licensed adult-use dispensaries only. Johnson rejected the measure, citing concerns that an outright prohibition would harm small businesses and adult consumers without effectively addressing safety or youth access issues. The veto holds despite a 32-16 council vote and highlights ongoing tensions around hemp THC regulation at municipal levels.

The Chicago decision reverberates beyond city limits, given national scrutiny over intoxicating hemp products and an impending federal deadline for Congress to establish new regulatory guidelines or risk a nationwide ban. Local policymakers and industry stakeholders are watching closely. Johnson’s choice could influence other cities and states confronting similar questions about how far to limit hemp-derived cannabinoids while balancing market health and public protection.

Federal Rule Finalized for CBD Coverage Under Medicare

A major federal policy shift emerged this week with the Centers for Medicare & Medicaid Services finalizing a rule to extend federal CBD coverage under Medicare, according to cannabis industry reporting. The guidance, confirmed by a hemp company executive collaborating with CMS, marks the first time such coverage has been put into regulatory text, signaling widening health-care integration for cannabinoids beyond recreational and medical cannabis markets. If implemented, the rule could open legal CBD products to millions of seniors and other Medicare beneficiaries, stimulating demand in a largely untapped segment.

The coverage rule comes amid a broader backdrop of federal cannabis uncertainty, including suspended rescheduling timelines and ongoing debates over THC regulation. While rescheduling of marijuana as a Schedule III substance remains unresolved, the Medicare CBD decision suggests targeted federal action is still possible in areas with clear public health benefits. Stakeholders say this could serve as a precedent for future CBD and even cannabis regulatory advances.

Florida Election Officials Undercount Cannabis Legalization Signatures

In a developing political flashpoint, Florida election officials appear to have failed to count more than 54,000 valid signatures for Smart & Safe Florida’s adult-use cannabis legalization ballot initiative. Analysis of county election data suggests local supervisors validated significantly more signatures than what state officials credited them with, potentially jeopardizing the initiative’s placement on the November ballot despite apparent compliance. This discrepancy has sparked calls for a review and could trigger legal challenges if Democratic and Republican leaders do not intervene.

The dispute highlights the broader strategy challenges facing cannabis legalization campaigns nationwide — even in states where public support is strong. Florida’s initiative, which would create one of the largest adult-use markets in the country if passed, has become a flashpoint in ongoing debates over signature verification, ballot access, and partisan election administration. A resolution, legislated or judicial, could be pivotal for the industry’s expansion in 2026.

Massachusetts Regulators Consider Freezing Cannabis Grow Licenses

In a striking regulatory move, Massachusetts cannabis regulators are considering a moratorium on new grow licenses to stabilize an already oversupplied market. Wholesale flower prices have plummeted, at one point averaging as low as about $14.20 per eighth, and multiple cultivation sites and retailers have shuttered operations amid falling returns and heightened operational costs. The Cannabis Control Commission is planning public hearings to explore a cultivation license freeze, potentially extending to other license categories if industry testimony supports the move.

Supporters say the pause could relieve pressure on prices and reduce downward stress on existing operators, especially those struggling with excess supply and low margins. Opponents warn that stifling new entrants could dampen innovation and create barriers to competition. As states grapple with market saturation and regulatory evolution, Massachusetts’ potential policy shift could set precedents for other mature adult-use markets looking to rebalance supply and demand.

U.S. Cannabis Stocks Attract Renewed Investor Interest as Markets Shift

Amid ongoing federal and state policy debate, U.S. marijuana stocks are drawing fresh investor attention heading into February 2026. Market analysts highlight that the sector’s valuation dynamic is shifting: companies with operational discipline, strong branding, and scalable operations are separating themselves from weaker peers even as broader industry volatility persists. Curaleaf, Green Thumb Industries, and Verano are cited as leading multi-state operators poised for growth in this transitional environment.

This renewed investor focus reflects a growing view that long-term fundamentals, rather than short-term policy headlines, will determine sector performance. While federal cannabis reform remains uncertain, incremental state-level legal expansions and consumer demand consistency continue to lend optimism to those tracking cannabis equities. Investors are increasingly prioritizing companies with clear paths to profitability and capital access as the sector matures past its early speculative phase.

Connecticut Cannabis Retailers Face Enforcement and Public Safety Scrutiny

In Connecticut, law enforcement made headlines by arresting two men and shutting down multiple smoke shops for selling cannabis illegally and to minors, highlighting enforcement priorities around licensed compliance. Authorities seized more than 7.6 pounds of THC products during investigations and charged suspects with unlicensed distribution and intent to sell to minors. State and local agencies also closed two additional shops due to labor violations.

The actions add to a growing national conversation about how to balance consumer access with robust enforcement against unlicensed and irresponsible operators. As regulators continue to tighten compliance frameworks, compliance failures like these provide cautionary tales for licensed retailers and policymakers alike, particularly in markets where adult-use legalization has created complex enforcement landscapes.